Previous Article | Next Article 
Journal of Virology, July 2001, p. 6460-6471, Vol. 75, No. 14
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6460-6471.2001
Repression of Vaccinia Virus Holliday Junction Resolvase Inhibits
Processing of Viral DNA into Unit-Length Genomes
Alonzo D.
Garcia and
Bernard
Moss*
Laboratory of Viral Diseases, National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, Maryland 20892-0445
Received 5 March 2001/Accepted 12 April 2001
 |
ABSTRACT |
The vaccinia virus A22R gene encodes a protein that is homologous
to the bacterial enzyme RuvC and specifically cleaves and resolves
four-way DNA Holliday junctions into linear duplex products. To
investigate the role of the vaccinia virus Holliday junction resolvase
during an infection, we constructed two recombinant viruses: vA22-HA,
which has a short C-terminal epitope tag appended to the A22R open
reading frame, and vA22i, in which the original A22R gene is deleted
and replaced by an inducible copy. Polyacrylamide gel electrophoresis
and Western blot analysis of extracts and purified virions from cells
infected with vA22-HA revealed that the resolvase was expressed after
the onset of DNA replication and incorporated into virion cores. vA22i
exhibited a conditional replication defect. In the absence of an
inducer, (i) viral protein synthesis was unaffected, (ii) late-stage
viral DNA replication was reduced, (iii) most of the newly synthesized
viral DNA remained in a branched or concatemeric form that caused it to
be trapped at the application site during pulsed-field gel
electrophoresis, (iv) cleavage of concatemer junctions was inhibited,
and (v) virion morphogenesis was arrested at an immature stage. These
data indicated multiple roles for the vaccinia virus Holliday junction
resolvase in the replication and processing of viral DNA into
unit-length genomes.
 |
INTRODUCTION |
Poxviruses encode many of the
proteins involved in the expression, replication, and packaging of
their DNA genomes in the cytoplasm of infected cells (33).
The mature genome of vaccinia virus (VV), the prototype member of this
large family of vertebrate and invertebrate viruses, is a linear
double-stranded molecule of about 185,000 bp with covalently linked
hairpin termini (2, 18). By mapping of
temperature-sensitive conditional lethal mutations, five viral genes
that are expressed early in infection and that are required for DNA
replication were identified. These genes encode a DNA polymerase
(11, 23, 47), a nucleic acid-independent nucleoside
triphosphatase (15, 16), a serine/threonine protein kinase
(36), a uracil DNA glycosylase (14, 31, 45,
48), and a protein that is a product of the A20R open reading
frame (ORF) (22) and that has been referred to as a
processivity factor (46). Although early-gene expression
is sufficient for VV DNA replication and recombination
(26), concatemeric forms of VV DNA accumulate in the
absence of late-gene expression, suggesting that a viral late-protein
functions as a resolvase (7, 30) or that late
transcription per se is needed (20, 44) or both.
The DNA that connects unit-length genomes is known as the concatemer
junction (3, 34). When transfected into infected cells,
plasmids containing the concatemer junction are resolved into
minigenomes with hairpin ends (8, 9, 27, 29). Because the
resolution sequence contains a functional late promoter, components of
the transcription system may be involved in DNA processing (20,
44). In this regard, conditional lethal capping enzyme mutants
are defective in concatemer resolution (5, 19). The concatemer junction contains an inverted repetition, which in supercoiled plasmids can form a cruciform structure resembling a
four-way Holliday junction (HJ) recombination intermediate (10, 28). Extracts of poxvirus-infected cells contain an HJ resolving activity (43). In addition, poxvirus-encoded topoisomerase
(40, 42) can cleave and ligate a variety of DNA
structures, including an HJ (35, 39). Recently, a specific
VV HJ resolvase was identified (17). No genetic data are
yet available, however, to determine if either the topoisomerase or the
HJ resolvase is involved in concatemer resolution in vivo.
The encoding of an HJ resolvase by the VV A22R ORF was suggested by
amino acid similarities to the bacterial enzyme RuvC and confirmed by
expression and characterization of the activity of a recombinant
A22R protein (17). Database searches indicated that RuvC
homologs are present in all poxviruses as well as an iridovirus. Here
we demonstrate the synthesis of the HJ resolvase during VV infection
and describe the construction and characterization of a recombinant VV
(rVV) with a stringently regulated A22R gene. Repression of A22R
expression resulted in decreased late-stage VV DNA replication,
accumulation of unprocessed DNA molecules with uncleaved concatemer
junctions, and interruption of virus morphogenesis prior to the
acquisition of infectivity.
 |
MATERIALS AND METHODS |
Cell lines and viruses.
BS-C-1 cells were grown in Eagle's
minimal essential medium (E-MEM) supplemented with 10% fetal bovine
serum (FBS). HeLa S3 and STO cells were grown in Dulbecco's minimal
essential medium with 10% FBS. All rVVs were derived from strain WR.
The rVV vT7lacOI (1) was propagated in HeLa S3 cells. The
rVV vA22/A22i (derived from vT7lacOI), containing a guanine
phosphoribosyltransferase gene (gpt), was isolated and
propagated in BS-C-1 cells in the presence of E-MEM containing
mycophenolic acid, hypoxanthine, xanthine, and 2.5% FBS
(13). The inducer-dependent rVV vA22i was isolated and
grown in BS-C-1 cells in E-MEM containing 50 µM
isopropyl-
-D-thiogalactopyranoside (IPTG) and
2.5% FBS. The rVV vA22-HA (derived from vA22i) was isolated in STO
cells by reverse gpt selection (21) and
propagated in HeLa S3 cells.
Plasmid construction and PCR.
For construction of rVVs, we
needed to insert an inducible copy of the A22R gene into the VV
hemagglutinin (HA) A56R locus and then delete the endogenous A22R gene.
However, because the A22R ORF in the VV genome overlaps the A20R ORF by
71 nucleotides and the predicted A23R gene promoter region by 23 nucleotides, the entire A22R gene could not be deleted. We considered
that if the 5' and 3' ends of the A22R ORF remained, then the
full-length ORF might be restored by recombination with the inducible
copy. To avoid sequence duplication, we made silent mutations
(designation "smt") in codons 152 to 187 of the inducible A22R ORF.
For isolation and detection purposes, we also added a C-terminal
histidine tag. Plasmid transfer vector pVOTE.1 (49) was
modified by deleting the encephalomyocarditis virus leader and was
named pVOT. Plasmid pcDNA-A22R-his containing the VV A22R ORF with a
six-histidine tag (17) was used as a template to make the
silent mutations and to include the six-histidine tag by PCR. The
resulting PCR product, A22Rsmt-his, was digested with NcoI
and BamHI, gel purified, and inserted into pVOT, resulting
in pVOT-A22Rsmt-his.
To remove the endogenous A22R gene, a 499-bp DNA segment that preceded
the A22R gene and a 556-bp DNA segment that followed it were amplified
by PCR using VV genomic DNA and two pairs of oligonucleotide primers. A
copy of the gus color selection gene with a synthetic
early-late viral promoter was amplified by PCR using
pZippy-gus/neo (a gift from T. Shors) as a template and the
oligonucleotide primers. The three PCR products were joined by a
two-step recombinant PCR procedure, resulting in a 2,907-bp PCR product
called 5'/3'A22-gus.
PCR was used to replace the six-histidine tag of pVOT-A22Rsmt-his with
the influenza virus HA epitope tag. A 416-bp DNA segment
that preceded
the endogenous A22R ORF and a 562-bp segment that
followed it were
amplified by PCR using VV genomic DNA and two
pairs of oligonucleotide
primers. The three products were joined
by recombinant PCR, resulting
in a 1,562-bp product. The latter
fragment was gel purified and ligated
into vector pCR2.1-TOPO
using a TOPO TA cloning kit
(Invitrogen).
rVV construction.
vA22i was constructed in two steps,
insertion of an inducible A22R gene and deletion of the endogenous one.
Approximately 106 BS-C-1 cells were infected with
vT7lacOI at a multiplicity of 0.2 for 1 h at 37°C. The infected
cells were washed twice with Opti-MEM (Life Technologies) and
transfected overnight with 2 µg of pVOT-A22Rsmt-his using
Lipofectamine (Life Technologies). The transfection mixture was
replaced with E-MEM containing 2.5% FBS, and the cells were harvested
at 48 h. Lysates were prepared by freezing and thawing three times
and sonicating for 30 s. Recombinant virus vA22/A22i was plaque
purified three times in selection medium containing mycophenolic acid,
hypoxanthine, and xanthine. Insertion of the A22Rsmt-his gene in the VV
HA locus was verified by PCR and gel electrophoresis. To remove the
endogenous A22R gene, BS-C-1 cells were infected with vA22/A22i at a
multiplicity of 1 and then transfected with 1 µg of 5'/3'A22-gus DNA.
Cells were harvested at 24 h, and lysates were prepared. The rVV
plaques were selected in the presence of 50 µM IPTG and identified by
staining with 0.1 µg of
5-bromo-4-chloro-3-indolyl-
-D-glucuronic acid (X-Gluc; Clontech Laboratories)/ml, and vA22i was plaque purified three times.
Small rVV stocks were prepared and tested for a conditional lethal
phenotype by plaque assays in the absence of IPTG. Replacement of the
endogenous A22R gene with the gus marker was confirmed by
PCR and gel electrophoresis.
vA22-HA was constructed in two steps, introduction of an A22R gene with
the influenza virus HA epitope tag at the C terminus
into the A22R
locus of vA22i and deletion of the inducible copy.
First,
10
6 BS-C-1 cells were infected with vA22i at a
multiplicity of 1;
after 1 h, they were transfected with 2 µg of
pCR2.1-A22Rsmt-HA
as described above. After 24 h, the cells were
harvested and cell
lysates were prepared. A plaque assay was carried
out in the absence
of IPTG, and rVV plaques were identified by the
absence of X-Gluc
staining. vA22-HA/A22i was plaque purified three
times, and the
presence of the A22Rsmt-HA gene in the A22R locus was
confirmed
by PCR and gel electrophoresis. Next, BS-C-1 cells were
infected
with vA22-HA/A22i and transfected with 2 µg of a 1,976-bp
PCR
product containing an intact A56R gene. vA22-HA was isolated using
STO cells in the presence of 0.1 mM 6-thioguanine by a reverse
gpt selection procedure (
21). Small rVV stocks
were prepared,
and the replacement of the inducible A22Rsmt-his gene
with the
A56R gene was confirmed by PCR and gel
electrophoresis.
Plaque assays and one-step growth curve.
BS-C-1 monolayers
in six-well plates were infected with 10-fold serial dilutions of VV
for 1 to 2 h. After adsorption, inocula were removed, E-MEM
containing 0.5% methylcellulose and 5% FBS and with or without 50 µM IPTG was added, and cells were incubated at 37°C for 2 days. The
cell monolayers were stained with crystal violet, and plaques were counted.
BS-C-1 cells in six-well plates were infected at a multiplicity of 5 for 1 h at 37°C. After absorption, inocula were removed,
cells
were washed twice with E-MEM containing 2.5% FBS, and E-MEM
with or
without 50 µM IPTG was added. At various times after infection,
cells
were harvested and lysates were prepared by freezing and
thawing three
times followed by sonication for 1 min. Virus titers
were determined by
plaque assays in the presence of 50 µM IPTG
if
required.
Western blot analysis.
Protein samples in 0.06 mM Tris-HCl
(pH 6.8)-2% (wt/vol) sodium dodecyl sulfate (SDS)-10% (vol/vol)
glycerol-0.001% (wt/vol) bromophenol blue-2.5% (vol/vol)
-mercaptoethanol were analyzed by electrophoresis through an SDS-4
to 20% gradient polyacrylamide gel (Owl Scientific) and transferred to
nitrocellulose (Protran BA85; Schleicher & Schuell). After blocking was
done with phosphate-buffered saline (PBS) containing 5% powdered milk
and 0.1% (vol/vol) Tween 20 for 1 h, membranes were incubated
with various primary antibodies for 2 h, followed by washes in PBS
containing 0.1% Tween 20. The membranes were then incubated with
appropriate secondary antibodies conjugated with horseradish peroxidase
for 45 min. Proteins were detected by chemiluminescence (SuperSignal
West Dura extended-duration substrate; Pierce). The primary antibodies
used were as follows: antitetrahistidine monoclonal antibody
(MAb; Qiagen), anti-HA MAb conjugated to horseradish peroxidase (Roche
Molecular Biochemicals), anti-H3L peptide antiserum (6a),
D12L antiserum (a gift from S. Shuman), and A3L peptide antiserum. The
secondary antibodies used were anti-mouse or anti-rabbit immunoglobulin
conjugated to horseradish peroxidase (Amersham).
Virus purification and detergent extraction.
Approximately
1.5 × 109 HeLa S3 cells grown in a
suspension culture were infected with vA22-HA at a multiplicity of 8 for 30 min at 37°C. At 72 h after infection, cells were
harvested, sedimented, resuspended in 10 mM Tris-HCl (pH 9.0), and
Dounce homogenized. VV in the cytoplasmic fraction was purified by
sedimentation through a 36% sucrose cushion followed by two successive
sucrose gradient sedimentations as previously described
(12). The concentration of the viral suspension was
determined from the optical density (OD) at 260 nm using the formula 1 OD unit equals 64 µg of virion protein/ml.
Approximately 50 µg of purified vA22-HA was incubated in 100 µl of
0.5% (vol/vol) Nonidet P-40 (NP-40)-50 mM Tris-HCl (pH
8.0) with or
without 50 mM dithiothreitol (DTT) for 30 min at
37°C. The soluble
membrane-associated proteins and insoluble core
protein
fractions were collected by centrifugation at 20,000 ×
g for 30 min at 4°C. Viral cores were resuspended in 0.2%
(wt/vol)
deoxycholate-100 mM Tris-HCl-250 mM NaCl-10 mM DTT and
incubated
on ice for 30 min. The insoluble proteins were pelleted by
centrifugation,
and the soluble core protein fraction was collected.
The various
protein fractions were analyzed by SDS-polyacrylamide gel
electrophoresis
(PAGE) followed by Western blotting or silver
staining.
Amino acid pulse-labeling.
BS-C-1 cell monolayers in 12-well
plates were infected with VV at a multiplicity of 5. After 1 h at
37°C, the cells were washed twice and incubated in the presence or
absence of 50 µM IPTG. At various times after incubation, the cells
were washed twice with methionine- and cysteine-free medium, incubated
in fresh medium of the same composition but containing 2.5% dialyzed
FBS for 30 min, and then labeled with 100 µCi of a mixture of
[35S]methionine and
[35S]cysteine/ml for 30 min at 37°C. Cells
were harvested and incubated in hypotonic buffer (10 mM Tris-HCl [pH
8.0], 10 mM KCl, 0.5 mM EDTA)-0.2% (vol/vol) NP-40-20 mM
-mercaptoethanol-1 mM CaCl2-0.2 mM
phenylmethylsulfonyl fluoride-10 µg of micrococcal nuclease per ml
for 30 min on ice. Nuclease digestions were stopped by adding 0.06 mM
Tris-HCl (pH 6.8)-2% (wt/vol) SDS-10% (vol/vol) glycerol-0.001%
(wt/vol) bromophenol blue-2.5% (vol/vol)
-mercaptoethanol.
Electron microscopy.
BS-C-1 cell monolayers were infected
with vA22i at a multiplicity of 10 at 37°C and washed twice 1 h
later with complete medium. Cells were incubated for 24 h in the
presence or absence of 50 µM IPTG. Cells were fixed with 2%
glutaraldehyde and embedded in Epon resin, and ultrathin-sectioned
samples were viewed on a Philips CM100 electron microscope
(50).
Analysis of viral DNA synthesis.
BS-C-1 cells in 12-well
dishes were infected with VV at a multiplicity of 5 for 1 h at
37°C and washed twice with complete medium. At various times after
infection, cells were harvested, sedimented, washed in PBS, resuspended
in 10× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate [pH
7.0])-1 M ammonium acetate, and lysed by freezing and thawing three
times to prepare total DNA. The DNA was either spotted directly onto a
BrightStar-Plus nylon membrane (Ambion) in duplicate using a slot blot
apparatus (Hoeffer) or digested with proteinase K, sonicated, and
denatured by incubation in 0.4 M NaOH-10 mM EDTA in a boiling water
bath for 10 min prior to being spotted onto the membrane. After being washed twice with 10× SSC, the membrane was soaked in denaturing solution (0.5 M NaOH, 1.5 NaCl), in neutralizing solution (1.5 M NaCl,
1 M Tris base), and in 5× SSC. DNA samples were UV cross-linked to the
nylon membrane with a Stratalinker 2400 (Stratagene). VV DNA was
detected using the Quik-Hyb protocol (Stratagene) with VV genome
HindIII A and D fragments that were
32P labeled using a random priming kit (Life
Technologies) and autoradiography. Radiolabeled DNA was quantified with
a PhosphorImager (Storm 860; Molecular Dynamics) and ImageQuant software.
Analysis of viral DNA by pulsed-field gel electrophoresis and
restriction endonuclease digestion.
BS-C-1 cell monolayers in
six-well plates were infected with VV at a multiplicity of 5 for 1 h, washed twice with complete E-MEM, and incubated in fresh medium of
the same composition but with or without 50 µM IPTG. At various times
after infection, cells were harvested, sedimented, washed with PBS,
dispersed at a concentration of 107 per ml in
suspension buffer (CHEF genomic DNA plug kit; Bio-Rad), warmed to
50°C, mixed with Clear-cut agarose (Bio-Rad) to a final concentration
of 0.75%, and formed into 100-µl agarose plugs. Agarose plugs were
incubated in a proteinase K reaction mixture (Bio-Rad) at 50°C for
24 h and then equilibrated in wash buffer (Bio-Rad). One-third of
an agarose plug (~33 µl) was loaded into a 1% agarose gel
(pulsed-field certified agarose; Bio-Rad), and electrophoresis was
carried out in 0.5× TBE (44.5 mM Tris-borate, 1 mM EDTA [pH 8.3])
using a CHEF-DRII apparatus (Bio-Rad). Pulsed-field electrophoresis was
performed at 5.8 V with a switching time gradient of 50 to 90 s
for 22 h at 14°C. The agarose gel was stained with 0.5 µg of
ethidium bromide per ml and UV irradiated on a transilluminator for 10 min, followed by soaking in 0.25 M HCl for 30 min to nick DNA. DNA was
transferred to an Immobilon-Ny+ nylon membrane (Millipore) and detected
by Southern blot hybridization using the Quik-Hyb protocol with VV
HindIII A and D fragments that were
32P labeled by random priming.
Concatemer junctions were analyzed by restriction enzyme digestion and
Southern blotting. Pellets of infected cells were suspended
in 50 µl
of 150 mM NaCl-20 mM Tris-HCl (pH 8.0)-10 mM EDTA and
then lysed in
250 µl of 20 mM Tris-HCl (pH 8.0)-10 mM EDTA-0.75%
SDS-0.4 mg of
proteinase K/ml. The reaction mixtures were incubated
for ~6 h at
37°C. The samples were extracted with phenol, phenol-chloroform,
and
chloroform before precipitation with ethanol. After drying,
DNA pellets
were resuspended in 10 mM Tris-HCl (pH 8.0) and passed
through a
25-gauge needle. The DNA concentration was calculated
by determining
the absorbance at 260 nm, based on 1 unit equaling
50 µg of DNA/ml. A
2-µg sample of DNA was digested with
BstEII
at 37°C,
subjected to electrophoresis through a 0.7% agarose gel
(SeaKem ME;
FMC), and transferred to an Immobilon-Ny+ nylon membrane.
DNA was
detected by Southern blot hydridization using a 5'
32P-end-labeled oligonucleotide complementary to
the 70-bp repeats
at the ends of the VV genome (
6).
 |
RESULTS |
Construction of a conditional lethal rVV with an inducible A22R
gene.
To gain insight into the role of the VV HJ resolvase during
infection, a mutant with an A22R gene regulated by a bacteriophage T7
promoter and the Escherichia coli lac repressor was
generated. The starting virus for this construction, vT7lacOI
(1), contained an inducible bacteriophage T7 RNA
polymerase gene and a constitutive E. coli lac repressor
gene (Fig. 1A). Inducible mutant virus
vA22i was constructed in two steps. First, a transfer plasmid
containing an inducible A22R gene with a six-histidine tag at the C
terminus (A22R-his) and the gpt selectable marker was
inserted into the VV HA gene (ORF A56R) of vT7lacOI by homologous
recombination. The resulting intermediate virus, vA22/A22i, was
selected in the presence of mycophenolic acid and contains both
inducible and endogenous A22R gene copies (Fig. 1A). The inducible
A22R-his ORF is preceded by the bacteriophage T7 promoter and the
E. coli lac operator, but the encephalomyocarditis virus
leader of the original system (49) was eliminated to
prevent cap-independent translation of potential upstream read-through
transcripts. The natural A22R gene was then deleted from vA22/A22i by
homologous recombination using DNA containing the gus color
selection marker gene. Plaques that formed in the presence of IPTG and
stained blue with X-Gluc were picked to yield vA22i (Fig. 1A). PCR was used to confirm the structure of the rVV at each stage of construction.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 1.
Construction of a conditional lethal mutant with an
inducible A22R gene. (A) Representations of relevant portions of the
genomes of vT7lacOI, vA22/A22i, and vA22i corresponding to the J2R
(thymidine kinase [TK]), A22R (HJ resolvase), and A56R (HA) genes.
Insertions of exogenous genes into these regions are depicted below the
diagrams. Abbreviations: PT7 and T7 pol, bacteriophage T7 promoter and
RNA polymerase gene, respectively; lac I and lacO, E.
coli lac repressor gene and lac
operator element, respectively; gus, color marker gene; gpt,
mycophenolic acid resistance gene; P11, P7.5, and P E/L, late,
early-late, and synthetic early-late VV promoters, respectively. (B)
Plaque formation. BS-C-1 cell monolayers were infected with wild-type
VV (WR), vA22/A22i, or vA22i in the absence ( ) or presence (+) of 50 µM IPTG. After 48 h, monolayers were stained with crystal violet
and photographed.
|
|
The ability of the rVVs to replicate and infect adjacent cells in the
presence and absence of IPTG was determined by plaque
assays.
vA22/A22i, which contains both inducible and unregulated
A22R genes,
produced plaques in the presence or absence of IPTG
(Fig.
1B). In
contrast, vA22i, which contains just an inducible
A22R-his gene,
produced plaques only in the presence of IPTG,
indicating that the HJ
resolvase was stringently regulated and
essential for virus
replication. Previous studies had shown that
the plaques formed by
vT7lacOI and derivatives were smaller than
those of the parental VV
strain WR, presumably due to the insertions
in the thymidine kinase and
HA genes, consistent with the small
difference in plaque sizes between
WR and the new rVVs (Fig.
1B).
Construction of an rVV with an epitope-tagged A22R gene.
To
facilitate the characterization of the HJ resolvase, we constructed a
second recombinant VV, in which the A22R ORF was engineered to contain
the influenza virus HA epitope tag at the C terminus while retaining
the authentic A22R genome location and transcriptional regulatory
signals. Construction of vA22-HA was performed in two steps, starting
with IPTG-dependent vA22i as the parental virus (Fig.
2A). This protocol provided a selection scheme and, by isolating a revertant virus, also assured us that vA22i
had no spurious gene defects. The A22R-HA ORF was inserted into the
A22R locus of vA22i by homologous recombination, and plaques that
formed in the absence of IPTG and did not stain with X-Gluc were
picked. The resulting intermediate virus (vA22-HA/A22i) contained the
epitope-tagged A22R gene but still had the inducible A22R-his gene
(Fig. 2A). Homologous recombination was then used to restore the VV HA
gene and thereby delete the inducible A22R-his gene as well as the
gpt gene from vA22-HA/A22i. Recombinant vA22-HA (Fig. 2A)
was isolated using a reverse gpt selection procedure (21) and characterized by PCR. Plaques formed by vA22-HA
were similar in size to those formed by WR (Fig. 2B), indicating that the epitope-tagged HJ endonuclease was fully functional.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Construction of an rVV with an HA epitope-tagged A22R
gene. (A) Representations of relevant portions of the genomes of vA22i,
vA22-HA/A22i, and vA22-HA. Abbreviations are the same as those used in
Fig. 1. (B). Plaque formation. BS-C-1 cell monolayers were infected
with wild-type VV or vA22-HA. After 48 h, monolayers were stained
with crystal violet and photographed.
|
|
Expression of the HJ resolvase during VV infection.
The HA
epitope tag on the A22R gene of vA22-HA provided a way to detect the
A22R protein by SDS-PAGE and Western blotting of infected cell
extracts. A doublet band was detected with an anti-influenza
virus HA MAb at 4 h after infection, and its intensity progressively increased with time (Fig.
3). As expected for a late protein, the
bands were not detected even after 24 h in the presence of
cytosine arabinoside, an inhibitor of DNA replication. The mass of the
upper band was estimated to be 23 kDa, similar to that expected for the
product of the A22R-HA ORF. The lower A22R-HA protein species
apparently resulted from internal initiation at an in-frame methionine
16 residues downstream of the start of the ORF. The late expression of
the HJ resolvase suggested involvement in the processing rather than
the synthesis of viral DNA.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 3.
HJ resolvase synthesis during virus infection. BS-C-1
cells were infected at a multiplicity of 5 in the absence or presence
of 44 µM cytosine arabinoside (AraC). At the indicated hours
postinfection (hpi), cells were lysed in hypotonic buffer containing
0.2% NP-40 and 10 µg of micrococcal nuclease per ml and analyzed by
Western blotting using a horseradish peroxidase-conjugated anti-HA
antibody. Proteins were detected by chemiluminescence. The positions
and masses of marker proteins are indicated. Arrows point to the
A22R-HA doublet.
|
|
The HJ resolvase is packaged in virion cores.
Virus from cells
infected with vA22-HA was purified by successive sucrose gradient
sedimentations, and individual fractions from the second
sedimentation were analyzed by OD measurement (Fig.
4A), SDS-PAGE and silver staining (not
shown), and Western blotting with an anti-HA MAb (Fig. 4A). The
fractions containing the A22R-HA doublet corresponded to those
containing virus particles. The purified virus particles were extracted
with 0.5% NP-40 in the absence or presence of 50 mM DTT. The membrane
and core fractions were then separated by centrifugation and analyzed
by SDS-PAGE and Western blotting (Fig. 4B) or silver staining (Fig.
4C). None of the A22R protein was extracted into the supernatant under
these conditions, indicating that it was entirely associated with the core (Fig. 4B). In contrast, considerable amounts of the H3L protein (Fig. 4B) and other membrane proteins (Fig. 4C) were released by the
nonionic detergent. The core was treated with deoxycholate and DTT and
separated into soluble and insoluble fractions. The A22R protein and
the major 4b (A3L) core structural protein were found entirely
in the insoluble fraction, whereas some capping enzyme (D12L) (Fig. 4B)
and other proteins (Fig. 4C) were found in the supernatant. We
concluded that the HJ resolvase is associated with virions and tightly
packaged in cores.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Association of the HJ resolvase with purified virions.
(A) Cosedimentation of the A22-HA protein with virus particles. Sucrose
gradient fractions were collected and analyzed for particles by light
scattering and for the A22-HA protein by Western blotting as described
in the legend to Fig. 3. (B) Detergent extraction of purified vA22-HA
virions. Virions were incubated with 0.5% NP-40 in the absence or
presence of 50 mM DTT, and the released membrane-associated and
insoluble core proteins were separated by centrifugation. The viral
cores were then resuspended in deoxycholate-containing lysis
buffer and separated by centrifugation into supernatant (S) and
pellet (P) fractions. The samples were analyzed by SDS-PAGE and Western
blotting using antibodies to the HA epitope tag, the H3L protein, the
large subunit of capping enzyme (D12L), and major core protein 4b
(A3L). (C) The fractions described in panel B were analyzed by SDS-PAGE
and silver staining.
|
|
Inducible expression of the HJ resolvase during infection with
vA22i.
The addition of six histidines to the C terminus of the
A22R ORF in vA22i allowed us to detect the HJ resolvase with antibody to the tag. Cells were infected in the presence or absence of IPTG and
harvested after 20 h. In the absence of IPTG, no protein band was
seen by SDS-PAGE and Western blotting (Fig.
5). A faint band of the expected size was
detected at the lowest concentration of IPTG (5 µM), and its
intensity increased with IPTG concentration (Fig. 5). We attributed the
finding of a single 23-kDa A22R-his band, instead of a doublet, to an
optimal Kozak translation initiation sequence (25)
engineered in the vA22i construct. In vA22-HA, the A22R-HA ORF retained
the natural translation initiation context, which was suboptimal.
Evidently, translation initiation at the downstream site was not
necessary for the replication of vA22i.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 5.
Inducer-dependent expression of the HJ resolvase. BS-C-1
cells were infected with 5 PFU of vA22i per cell in the absence
(0) or presence of 5 to 250 µM IPTG. Cells were
harvested after 20 h and analyzed by SDS-PAGE and Western blotting
using an antitetrahistidine antibody. Proteins were detected by
chemiluminescence. The positions and masses of marker proteins are
indicated.
|
|
Inducer-dependent replication of vA22i.
Plaque assays had
indicated that the replication of vA22i was stringently repressed in
the absence of IPTG (Fig. 1B). One-step growth yield assays were
carried out to determine the IPTG dependence under conditions to be
used for biochemical experiments. BS-C-1 cells, in the presence or
absence of 50 µM IPTG, were infected with vA22i, vA22/A22i, or WR at
a multiplicity of 5. In the presence of IPTG, the yield of vA22i
started to plateau by 12 h, and the final yield was similar to
that of vA22/A22i and only slightly lower than that of WR (Fig.
6). In the absence of IPTG the yield of
vA22i at 12 h was more than 2 log units lower than that in the
presence of the inducer. At later times, however, there was a gradual
increase in the titer of vA22i so that the difference was less than 2 log units at 24 h and approximately 1 log unit at 48 h.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
Inducer-dependent replication of vA22i. BS-C-1 cells
were infected with 5 PFU of WR, vA22/A22i, or vA22i in the absence or
presence of 50 µM IPTG. At the indicated times, the cells were
harvested and virus titers were determined by plaque assays in the
presence of IPTG. Upper bars of standard deviations are shown.
|
|
Effect of A22R repression on viral DNA synthesis.
Considering
that the known viral proteins required for DNA replication are encoded
by early genes, the late expression of the A22R gene seemed to make
such a role for the HJ resolvase unlikely. Nevertheless, to evaluate
the effect of repression of the A22R gene on viral DNA synthesis,
BS-C-1 cells were infected with vA22i in the absence and presence of 50 µM IPTG or with vA22/A22i or WR as a control. At various times, the
infected cells were harvested and total DNA was prepared from the
infected cell lysates. Viral DNA accumulation was quantified by
spotting the samples directly onto membranes followed by denaturation
and hybridization in situ with a 32P-labeled
viral DNA probe. For the first 6 h, viral DNA accumulated at
similar rates under all conditions (Fig.
7A). However, at subsequent times, viral
DNA accumulated more slowly in cells infected with vA22i in the absence
of IPTG than in its presence. We considered that the decrease might
have been an artifact due to the formation of branched DNA molecules
that were difficult to denature for hybridization while bound to the
membrane. However, a similar result was obtained when the DNA samples
were deproteinized, sheared, and denatured in alkali at 100°C prior
to slot blot analysis (Fig. 7B). These results indicated that the HJ
resolvase was needed to maintain a high rate of viral DNA replication.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 7.
Synthesis of viral DNA. BS-C-1 cells were infected with
5 PFU of WR, vA22/A22i, or vA22i in the absence or presence of 50 µM
IPTG. At the indicated times, the cells were harvested and lysed in a
high-salt solution. (A) Duplicate DNA samples were spotted directly
onto a membrane and hybridized to 32P-labeled VV DNA. (B)
DNA samples were deproteinized, sonicated, and denatured with alkali at
~100°C prior to spotting onto a membrane and hybridization.
Radioactivity was measured with a PhosphorImager and quantified with
ImageQuant software.
|
|
Inhibition of viral DNA processing under nonpermissive
conditions.
Because of the ability of the A22R protein to resolve
HJs, we were most interested in examining the viral DNA that formed under nonpermissive conditions. DNA from cells infected with WR or
vA22i in the presence or absence of IPTG was analyzed by pulsed-field gel electrophoresis and Southern blotting. Genome-length (185-kbp) DNA
was detected at 2 h and accumulated along with smaller amounts of
putative dimer and trimer species with time (Fig.
8B). Some viral DNA also remained at the
top of the gel (Fig. 8B) along with high-molecular-weight cellular DNA
detected by ethidium bromide staining (not shown). A similar
pattern of DNA accumulation occurred in cells infected with vA22i in
the presence of IPTG, although the DNA bands were first detected at
4 h and there was an additional band between the monomer and the
dimer species (Fig. 8A). In contrast, when cells were infected with
vA22i in the absence of IPTG, nearly all the viral DNA remained at the
top of the gel for the first 12 h (Fig. 8A). At 24 h after
infection, however, monomer, dimer, and trimer species were detected,
although at levels achieved within 6 h in the presence of the
inducer. The appearance of some unit-length genome DNA at 24 h in
the absence of IPTG correlated with the rise in infectivity noted
earlier (Fig. 6).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 8.
Analysis of viral DNA by pulsed-field gel
electrophoresis. BS-C-1 cells were infected with a 5 PFU of vA22i in
the absence or presence of 50 µM IPTG (A) or WR (B). Cells were
harvested at the indicated times (hpi, hours postinfection) and
embedded in agarose. The DNA was subjected to pulsed-field
electrophoresis, transferred onto a nylon membrane, and hybridized with
32P-labeled VV DNA. An autoradiograph is shown with the
position of the wells and DNA size markers on the left. The positions
of monomer (M) and dimer (D) viral genomes are indicated by arrows on
the right.
|
|
Accumulation of viral concatemer junctions under nonpermissive
conditions.
The DNA trapped at the top of the pulsed-field gel
could represent branched or concatemeric species. Restriction enzyme
analysis of DNA from infected cells has been used to detect concatemer junctions. The hairpin ends of mature VV genomes with two sets of
tandem repeats separated by a BstEII site are depicted in
Fig. 9A. An unresolved concatemer
junction is shown above the hairpin ends (Fig. 9A). BstEII
digestion of the concatemer junction and hairpin termini would yield
2.6- and 1.3-kbp fragments, respectively, that would hybridize to a
32P-labeled oligonucleotide containing repeat
sequences. Previous experiments had shown that the 2.6-kbp concatemer
junction fragment was faintly and transiently detected early in
infection with wild-type VV (3). In contrast, the junction
accumulated when cells were infected with mutant viruses that were
defective in concatemer resolution (30). Resolved hairpin
termini were detected in DNA from cells infected for 4 or more hours
with wild-type VV (Fig. 9B), consistent with the time of appearance of
unit-length genomes. The concatemer junction fragment could barely be
detected. A similar pattern occurred when cells were infected with
vA22/A22i in the absence of IPTG (Fig. 9C). The junction fragment was
seen at 4 h after infection with vA22i in the presence of IPTG but
was barely discerned at 6 h and was undetectable at later times
(Fig. 9C). Correspondingly, the resolved hairpin ends accumulated in
the presence of IPTG, as shown by intense bands (Fig. 9C). In contrast, the junction fragment persisted and accumulated with time in cells infected with vA22i in the absence of IPTG (Fig. 9C), even though total
viral DNA synthesis was reduced under these conditions. A fragment
corresponding to the hairpin ends was faint but accumulated slightly by
24 h in the absence of IPTG (Fig. 9C). These data indicated that
the expression of A22R is required for the efficient resolution of
concatemer junctions. Further studies are needed to determine whether
the DNA also contains branches.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 9.
Analysis of concatemer junctions. (A) Diagram of a
concatemer junction (J) and mature hairpin termini (T).
BstEII cleavage sites are shown. (B and C) BS-C-1 cells
were infected with WR (B) or with vA22/A22i or vA22i in the absence
( ) or presence (+) of 50 µM IPTG (C). At the indicated times (hpi,
hours postinfection), DNA was purified; 2 µg was digested with
restriction enzyme BstEII, electrophoresed through an
agarose gel, transferred onto a nylon membrane, and hybridized with a
32P-labeled oligonucleotide complementary to the repeated
sequence near the ends of the genome. The positions of monomer termini
(T) and concatemer junction (J) intermediates are indicated by
arrows.
|
|
Synthesis of viral protein under nonpermissive conditions.
Previous studies had shown that the resolution of concatemer junctions
was inhibited when cells were infected with mutant viruses that have a
global block in viral late-protein synthesis (7, 30). We
were therefore curious to determine whether viral late-protein
synthesis was also blocked in cells infected with vA22i under
nonpermissive conditions. This was of particular concern because of
decreased viral DNA replication which occurred at late times after
nonpermissive infection with vA22i. To investigate viral protein
synthesis, cells were infected with WR, vA22/A22i, or vA22i in the
presence or absence of IPTG. The cells were labeled with
[35S]methionine and
[35S]cysteine for 30 min at various times after
infection. Under all conditions, the patterns of viral protein
synthesis were very similar, and viral late proteins were
detected at 5 h and later times (Fig.
10). The only difference between cells
infected with vA22i and other viruses was the appearance of a
65-kDa band that probably represented the gus protein.

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 10.
Viral protein synthesis under permissive and
nonpermissive conditions. BS-C-1 cell monolayers were infected with 5 PFU (per cell) of WR, vA22/A22i, or vA22i in the absence ( ) or
presence (+) of 50 µM IPTG. At the indicated hour postinfection
(hpi), cells were labeled with a mixture of
[35S]methionine and [35S]cysteine for 30 min. The labeled proteins were analyzed by SDS-PAGE and
autoradiography. Lanes U contain proteins from uninfected cells. G,
position of the band presumed to be the gus protein,
which is present only in vA22i samples. The positions and masses of
marker proteins are indicated.
|
|
The proteolytic processing of certain core proteins is dependent on
virus maturation (
24). Pulse-chase experiments indicated
that cleavage of P4a and P4b to 4a and 4b was reduced in cells
infected with vA22i in the absence of IPTG compared to that in
cells
infected with WR, vA22/A22i, or vA22i in the presence of
IPTG (data not
shown), consistent with the inhibition of virus
morphogenesis
documented in the next
section.
Effect of A22R repression on virus morphogenesis.
Cells
infected with vA22i in the presence or absence of IPTG were examined by
electron microscopy. Typically, virus assembly occurs asynchronously,
and immature and mature virions can be detected in the same cell. This
was the case for cells infected in the presence of IPTG, where circular
immature virions as well as brick-shaped mature virions were seen at
24 h (Fig. 11). In the absence of
IPTG, there were mainly immature virus particles, some of which had
nucleoids, and dense spherical particles (Fig. 11). The latter
resembled aberrant virions lacking DNA that were previously found in
cells infected with a DNA-packaging mutant (6). The
"eye-ball" appearance of some structures that appeared to be
detached from the cell is actually dense spherical particles with a
ring of cytoplasm in tangentially cut microvilli. However, there were
additional dense spherical particles without the ring of cytoplasm that
were probably externalized.

View larger version (147K):
[in this window]
[in a new window]
|
FIG. 11.
Electron microscopy of cells infected with vA22i.
BS-C-1 cells were infected with vA22i at a multiplicity of 10 in the
absence ( ) or presence (+) of 50 µM IPTG. After 24 h, the
cells were harvested, fixed, and embedded in Epon. Ultrathin sections
were prepared for electron microscopy. Abbreviations: IV, immature
virion; n, nucleoid; D, dense immature virion; IMV, intracellular
mature virion; CEV, cell-associated enveloped virion; IEV,
intracellular mature enveloped virion.
|
|
 |
DISCUSSION |
It was previously reported that the A22R ORF encodes an E. coli RuvC homolog with specific HJ resolvase activity
(17). In this follow-up study, we have shown that the HJ
resolvase is expressed late in infection, packaged in virus particles,
and required for efficient late-stage DNA replication and processing of
DNA concatemers into unit-length genomes. These important functions of
the HJ resolvase are consistent with the presence of A22R orthologs in all sequenced poxviruses.
To facilitate studies of the HJ resolvase, we made an rVV in which the
A22R ORF had a C-terminal epitope tag but remained under the control of
its natural promoter. Synthesis of the HJ resolvase was prevented by an
inhibitor of DNA replication but was detected at about 4 h after a
normal infection and then increased with time, as predicted from the
late promoter consensus sequence. Like many late proteins, the HJ
resolvase was associated with the cores of purified virus particles.
This localization makes it necessary to consider whether the resolvase
has a role in DNA packaging or at an early step in infection, although
it may simply reflect the abundance of the HJ resolvase in viroplasm
that is incorporated into assembling virus particles. As discussed
below, the presence of the enzyme in virions affects the interpretation of some experiments.
A genetic approach was taken to determine the role of the HJ resolvase.
vA22i, an inducible conditional lethal mutant VV that expresses
bacteriophage T7 RNA polymerase and the E. coli lac repressor, was constructed. The stringency of the system is based on
the use of two E. coli lac operators: one regulating the
expression of T7 RNA polymerase and the other regulating the activity
of a T7 promoter adjacent to the A22R gene (49). The
original system was designed for high-level expression and contains
part of the encephalomyocarditis virus leader sequence to allow
cap-independent translation. In a modified version of the expression
system used here, we removed this leader sequence to preclude
cap-independent translation of late RNAs that initiated upstream of the
T7 promoter and continued past the operator. In cells infected with
vA22i, expression of the HJ resolvase was dependent on IPTG, and the protein could not be detected by Western blotting in the absence of the
inducer. Consistent with this finding, vA22i plaque formation was
stringently repressed under these conditions. Under one-step virus
growth conditions, vA22i replication started to plateau at 12 h in
the presence of IPTG. In the absence of the inducer, virus replication
was undetectable at the latter time but occurred at a low rate over the
next 36 h. We considered several possible explanations for the
delayed virus production. One is that a low level of the HJ resolvase
was made but not detected by Western blotting. Another possibility is
the relatively high multiplicity used for the one-step growth
experiment (5 PFU, or ~100 particles/cell), compared to 1 particle in
a plaque assay, coupled with the fact that HJ resolvase is packaged in
virus particles. A third possibility is that the requirement for the HJ
resolvase is not absolute and that there are other DNA-processing
mechanisms involving other viral or cellular proteins, such as
topoisomerase, which is known to cleave HJs in vitro (35,
39). The latter explanation would imply the possibility of
isolating a viable, although poorly replicating, deletion mutant. An
effort to obtain such a virus is under way.
To investigate the defect in the formation of infectious virus, we
analyzed viral DNA synthesis and processing. In cells infected with
wild-type VV or vA22i under permissive or nonpermissive conditions, viral DNA accumulation was similar up to 6 h after infection. However, at later times, viral DNA accumulated much more slowly in
cells infected with vA22i in the absence of the inducer than in the
presence of the inducer. This result was reminiscent of bacteriophage
T4, in which origin initiation of DNA replication is programmed to
cease and recombinational mechanisms become important at late times
(32). In circumstances where the DNA primase is deficient,
bacteriophage T4 endonuclease VII facilitates the priming of DNA
synthesis by a mechanism involving the cleavage of recombinant junctions. Such a pathway may be relevant for VV, as no poxvirus primase has been identified and the nuclear location of the cellular primase could preclude its use for cytoplasmic viral DNA replication. In this model, the 3' ends produced by the VV HJ resolvase might prime
DNA synthesis. The accumulation of extensively branched DNA molecules,
discussed below, also could contribute to the slowing down of VV DNA
synthesis under nonpermissive conditions.
A previous study had demonstrated that sufficient viral DNA is made by
6.5 h after infection for a nearly normal yield of VV
(37). Therefore, it seemed unlikely that the observed
defect in DNA synthesis could entirely account for the inhibition of vA22i yield under nonpermissive conditions. Based on the in vitro activity of the HJ resolvase, we suspected that there was also a block
in the processing of the replicated viral DNA. We used pulsed-field gel
electrophoresis, a technique previously used to resolve full-length and
concatemeric forms of poxvirus DNA (7, 30), to examine
this idea. Under conditions of permissive infection, genome-length
viral DNA species were detected at 4 h after infection; however,
they were not detected until 24 h under nonpermissive conditions.
Prior to that time, the viral DNA was found exclusively at the top of
the gel, corresponding to the application site. The late appearance of
unit-length genomes correlated with the delayed rise in infectivity in
the absence of the inducer.
Nonmigrating DNA species are also seen under normal conditions and have
been thought to represent branched, concatemeric networks (7,
30). To further characterize the role of the HJ resolvase, we
specifically analyzed the viral DNA by restriction endonuclease analysis for the presence of concatemer junctions (3).
Under permissive conditions, uncleaved concatemer junctions were
detected at 4 h after infection but were difficult to see at later
times. In contrast, concatemer junctions increased in amount and
persisted for at least 24 h under nonpermissive conditions. This
result could be readily explained if the concatemer junction is a
substrate for the HJ resolvase. Supporting such an idea are data
indicating that the concatemer junction can assume an HJ-like structure
in a supercoiled plasmid (28) and that the HJ endonuclease
can resolve such a structure in vitro (A. Garcia, unpublished data). Nevertheless, other explanations were considered. One was a general defect in viral late-gene expression, which is known to inhibit concatemer resolution (7, 30), perhaps as a result of the reduced DNA replication at late times. However, metabolic labeling of
vA22i-infected cells revealed a normal level of viral late-protein synthesis under nonpermissive conditions. It will be important to
determine whether the DNA made under nonpermissive conditions is highly
branched and whether the HJ resolvase has debranching activity.
Although we favor the idea that the HJ resolvase directly cleaves
concatemer junctions, it is also possible that the primary role of this
enzyme is to resolve DNA networks and that another enzyme, such as
topoisomerase (35, 38), resolves concatemer junctions.
Failed attempts to delete the topoisomerase gene from VV suggested that
it is essential (41), but the absence of conditional lethal topoisomerase mutants has prevented efforts to determine its
role. Temperature-sensitive mutations in either the small or the large
subunits of capping enzyme result in a defect in DNA concatemer
resolution that is not understood but appears to be independent of a
general defect in viral protein synthesis (5, 19).
A defect in viral morphogenesis occurred when cells were infected with
vA22i in the absence of the inducer. Brick-shaped mature virions were
rare, and the predominant structures were immature virions and dense
spherical particles similar to ones previously shown to lack DNA and to
form when cells were infected with an A32L mutant defective in DNA
packaging (6). Under normal conditions of VV infection,
unit-length genomes are packaged and branched or concatemeric forms are
apparently excluded. For bacteriophage T4, DNA processing is associated
with assembly; endonuclease VII debranches replicated DNA, and a
capsid-associated endonuclease cleaves the concatemers
(4). In contrast, the resolution of VV DNA concatemers
occurs even when assembly is blocked at an early stage by the drug
rifampin (30) or at a later stage with a DNA-packaging
mutant (6).
In summary, the results presented here indicate that the A22R protein
is involved in late-stage DNA replication, resolution of concatemer
junctions, formation of unit-length genomes, and morphogenesis of virus
particles. If bacteriophage T4 is a guide, then the replication,
recombination, and processing of VV DNA may be interconnected with
alternative pathways.
 |
ACKNOWLEDGMENTS |
We thank Norman Cooper for maintaining cells and Andrea Weisberg
for electron microscopy.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 4 Center Dr.,
MSC 0445, NIH, Bethesda, MD 20892-0445. Phone: (301) 496-9869. Fax:
(301) 480-1147. E-mail: bmoss{at}nih.gov.
 |
REFERENCES |
| 1.
|
Alexander, W. A.,
B. Moss, and T. R. Fuerst.
1992.
Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.
J. Virol.
66:2934-2942[Abstract/Free Full Text].
|
| 2.
|
Baroudy, B. M.,
S. Venkatesan, and B. Moss.
1982.
Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain.
Cell
28:315-324[CrossRef][Medline].
|
| 3.
|
Baroudy, B. M.,
S. Venkatesan, and B. Moss.
1982.
Structure and replication of vaccinia virus telomeres.
Cold Spring Harbor Symp. Quant. Biol.
47:723-729.
|
| 4.
|
Black, L. W.
1995.
DNA packaging and cutting by phage terminases: control in phage T4 by a synaptic mechanism.
Bioessays
17:1025-1030[CrossRef][Medline].
|
| 5.
|
Carpenter, M. S., and A. M. DeLange.
1991.
A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution.
J. Virol.
65:4042-4050[Abstract/Free Full Text].
|
| 6.
|
Cassetti, M. C.,
M. Merchlinsky,
E. J. Wolffe,
A. S. Weisberg, and B. Moss.
1998.
DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.
J. Virol.
72:5769-5780[Abstract/Free Full Text].
|
| 6a.
|
da Fonseca, F. G.,
A. Weisberg,
E. J. Wolffe, and B. Moss.
2000.
Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail.
J. Virol.
74:7508-7517[Abstract/Free Full Text].
|
| 7.
|
DeLange, A. M.
1989.
Identification of temperature-sensitive mutants of vaccinia virus that are defective in conversion of concatemeric replicative intermediates to the mature linear DNA genome.
J. Virol.
63:2437-2444[Abstract/Free Full Text].
|
| 8.
|
DeLange, A. M., and G. McFadden.
1987.
Efficient resolution of replicated poxvirus telomeres to native hairpin structures requires two inverted symmetrical copies of a core target DNA sequence.
J. Virol.
61:1957-1963[Abstract/Free Full Text].
|
| 9.
|
DeLange, A. M.,
M. Reddy,
D. Scraba,
C. Upton, and G. McFadden.
1986.
Replication and resolution of cloned poxvirus telomeres in vivo generate linear minichromosomes with intact viral hairpin termini.
J. Virol.
59:249-259[Abstract/Free Full Text].
|
| 10.
|
Dickie, P.,
A. R. Morgan, and G. McFadden.
1987.
Cruciform extrusion in plasmids bearing the replicative intermediate configuration of a poxvirus telomere.
J. Mol. Biol.
196:541-558[CrossRef][Medline].
|
| 11.
|
Earl, P. L.,
E. V. Jones, and B. Moss.
1986.
Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene.
Proc. Natl. Acad. Sci. USA
83:3659-3663[Abstract/Free Full Text].
|
| 12.
|
Earl, P. L., and B. Moss.
1991.
Characterization of recombinant vaccinia viruses and their products, p. 16.18.1-16.18.10.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates & Wiley Interscience, New York, N.Y.
|
| 13.
|
Earl, P. L., and B. Moss.
1991.
Generation of recombinant vaccinia viruses, p. 16.17.1-16.17.16.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates & Wiley Interscience, New York, N.Y.
|
| 14.
|
Ellison, K. S.,
W. Peng, and G. McFadden.
1996.
Mutations in active-site residue of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability.
J. Virol.
70:7965-7973[Abstract].
|
| 15.
|
Evans, E.,
N. Klemperer,
R. Ghosh, and P. Traktman.
1995.
The vaccinia virus D5 protein, which is required for DNA replication, is a nucleic acid-independent nucleotide triphosphatase.
J. Virol.
69:5353-5361[Abstract].
|
| 16.
|
Evans, E., and P. Traktman.
1992.
Characterization of vaccinia virus DNA replication mutants with lesions in the D5 gene.
Chromosoma
102:S72-S82[CrossRef][Medline].
|
| 17.
|
Garcia, A. D.,
L. Aravind,
E. V. Koonin, and B. Moss.
2000.
Bacterial-type DNA Holliday junction resolvases in eukaryotic viruses.
Proc. Natl. Acad. Sci. USA
97:8926-8931[Abstract/Free Full Text].
|
| 18.
|
Geshelin, P., and K. I. Berns.
1974.
Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA.
J. Mol. Biol.
88:785-796[CrossRef][Medline].
|
| 19.
|
Hassett, D. E.,
J. I. Lewis,
X. Xing,
L. DeLange, and R. C. Condit.
1997.
Analysis of a temperature-sensitive vaccinia virus mutant in the viral mRNA capping enzyme isolated by clustered charge-to-alanine mutagenesis and transient dominant selection.
Virology
238:391-409[CrossRef][Medline].
|
| 20.
|
Hu, F.-Q., and D. J. Pickup.
1991.
Transcription of terminal loop region of vaccinia virus DNA is initiated from telomere sequences directing DNA resolution.
Virology
181:716-720[CrossRef][Medline].
|
| 21.
|
Isaacs, S. N.,
G. J. Kotwal, and B. Moss.
1990.
Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses.
Virology
178:626-630[CrossRef][Medline].
|
| 22.
|
Ishii, K., and B. Moss.
2001.
Evidence for a role of the vaccinia virus A20R protein in DNA replication determined by clustered charge-to-alanine mutagenesis.
J. Virol.
75:1656-1663[Abstract/Free Full Text].
|
| 23.
|
Jones, E. V., and B. Moss.
1984.
Mapping of the vaccinia virus DNA polymerase gene by marker rescue and cell-free translation of selected mRNA.
J. Virol.
49:72-77[Abstract/Free Full Text].
|
| 24.
|
Katz, E., and B. Moss.
1970.
Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.
Proc. Natl. Acad. Sci. USA
6:677-684.
|
| 25.
|
Kozak, M.
1989.
Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems.
Mol. Cell. Biol.
9:5073-5080[Abstract/Free Full Text].
|
| 26.
|
Merchlinsky, M.
1989.
Intramolecular homologous recombination in cells infected with temperature-sensitive mutants of vaccinia virus.
J. Virol.
63:2030-2035[Abstract/Free Full Text].
|
| 27.
|
Merchlinsky, M.
1990.
Mutational analysis of the resolution sequence of vaccinia virus DNA essential sequence consists of two separate AT-rich regions highly conserved among poxviruses.
J. Virol.
64:5029-5035[Abstract/Free Full Text].
|
| 28.
|
Merchlinsky, M.,
C. Garon, and B. Moss.
1988.
Molecular cloning and sequence of the concatemer junction from vaccinia virus replicative DNA: viral nuclease cleavage sites in cruciform structures.
J. Mol. Biol.
199:399-413[CrossRef][Medline].
|
| 29.
|
Merchlinsky, M., and B. Moss.
1986.
Resolution of linear minichromosomes with hairpin ends from circular plasmids containing vaccinia virus concatemer junctions.
Cell
45:879-884[CrossRef][Medline].
|
| 30.
|
Merchlinsky, M., and B. Moss.
1989.
Resolution of vaccinia virus DNA concatemer junctions requires late gene expression.
J. Virol.
63:1595-1603[Abstract/Free Full Text].
|
| 31.
|
Millns, A. K.,
M. S. Carpenter, and A. M. DeLange.
1994.
The vaccinia virus-encoded uracil DNA glycosylase has an essential role in viral DNA replication.
Virology
198:504-513[CrossRef][Medline].
|
| 32.
|
Mosig, G.
1998.
Recombination and recombination-dependent DNA replication in bacteriophage T4.
Annu. Rev. Genet.
32:379-413[CrossRef][Medline].
|
| 33.
|
Moss, B.
1996.
Poxviridae: the viruses and their replication, p. 2637-2671.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 34.
|
Moyer, R. W., and R. L. Graves.
1981.
The mechanism of cytoplasmic orthopoxvirus DNA replication.
Cell
27:391-401[CrossRef][Medline].
|
| 35.
|
Palaniyar, N.,
E. Gerasimopoulos, and D. H. Evans.
1999.
Shope fibroma virus DNA topoisomerase catalyses Holliday junction resolution and hairpin formation in vitro.
J. Mol. Biol.
287:9-20[CrossRef][Medline].
|
| 36.
|
Rempel, R. E., and P. Traktman.
1992.
Vaccinia virus-B1 kinase phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins.
J. Virol.
66:4413-4426[Abstract/Free Full Text].
|
| 37.
|
Salzman, N. P.
1960.
The rate of formation of vaccinia deoxyribonucleic acid and vaccinia virus.
Virology
10:150-152[CrossRef][Medline].
|
| 38.
|
Sekiguchi, J.,
C. Cheng, and S. Shuman.
2000.
Resolution of a Holliday junction by vaccinia topoisomerase requires a spacer DNA segment 3' of the CCCTT arrow cleavage sites.
Nucleic Acids Res.
28:2658-2663[Abstract/Free Full Text].
|
| 39.
|
Sekiguchi, J.,
N. C. Seeman, and S. Shuman.
1996.
Resolution of Holliday junctions by eukaryotic DNA topoisomerase I.
Proc. Natl. Acad. Sci. USA
93:785-789[Abstract/Free Full Text].
|
| 40.
|
Shaffer, R., and P. Traktman.
1987.
Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme.
J. Biol. Chem.
262:9309-9315[Abstract/Free Full Text].
|
| 41.
|
Shuman, S.,
M. Golder, and B. Moss.
1989.
Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: evidence that the gene is essential for virus growth.
Virology
170:302-306[CrossRef][Medline].
|
| 42.
|
Shuman, S., and B. Moss.
1987.
Identification of a vaccinia virus gene encoding a type I DNA topoisomerase.
Proc. Natl. Acad. Sci. USA
84:7478-7482[Abstract/Free Full Text].
|
| 43.
|
Stuart, D.,
K. Ellison,
K. Graham, and G. McFadden.
1992.
In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease.
J. Virol.
66:1551-1563[Abstract/Free Full Text].
|
| 44.
|
Stuart, D.,
K. Graham,
M. Schreiber,
C. Macaulay, and G. McFadden.
1991.
The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter.
J. Virol.
65:61-70[Abstract/Free Full Text].
|
| 45.
|
Stuart, D. T.,
C. Upton,
M. A. Higman,
E. G. Niles, and G. McFadden.
1993.
A poxvirus-encoded uracil DNA glycosylase is essential for virus viability.
J. Virol.
67:2503-2512[Abstract/Free Full Text].
|
| 46.
|
Traktman, P.
1996.
Poxvirus DNA replication, p. 775-793.
In
M. L. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 47.
|
Traktman, P.,
R. C. Sridhar, and B. E. Roberts.
1984.
Transcriptional mapping of the DNA polymerase gene of vaccinia virus.
J. Virol.
49:125-131[Abstract/Free Full Text].
|
| 48.
|
Upton, C.,
D. T. Stuart, and G. McFadden.
1993.
Identification of a poxvirus gene encoding a uracil DNA glycosylase.
Proc. Natl. Acad. Sci. USA
90:4518-4522[Abstract/Free Full Text].
|
| 49.
|
Ward, G. A.,
C. K. Stover,
B. Moss, and T. R. Fuerst.
1995.
Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells.
Proc. Natl. Acad. Sci. USA
92:6773-6777[Abstract/Free Full Text].
|
| 50.
|
Wolffe, E. J.,
D. M. Moore,
P. J. Peters, and B. Moss.
1996.
Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis.
J. Virol.
70:2797-2808[Abstract].
|
Journal of Virology, July 2001, p. 6460-6471, Vol. 75, No. 14
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6460-6471.2001
This article has been cited by other articles:
-
Jesus, D. M., Costa, L. T., Goncalves, D. L., Achete, C. A., Attias, M., Moussatche, N., Damaso, C. R.
(2009). Cidofovir Inhibits Genome Encapsidation and Affects Morphogenesis during the Replication of Vaccinia Virus. J. Virol.
83: 11477-11490
[Abstract]
[Full Text]
-
Senkevich, T. G., Koonin, E. V., Moss, B.
(2009). Predicted poxvirus FEN1-like nuclease required for homologous recombination, double-strand break repair and full-size genome formation. Proc. Natl. Acad. Sci. USA
106: 17921-17926
[Abstract]
[Full Text]
-
Satheshkumar, P. S., Anton, L. C., Sanz, P., Moss, B.
(2009). Inhibition of the Ubiquitin-Proteasome System Prevents Vaccinia Virus DNA Replication and Expression of Intermediate and Late Genes. J. Virol.
83: 2469-2479
[Abstract]
[Full Text]
-
Culyba, M. J., Hwang, Y., Minkah, N., Bushman, F. D.
(2009). DNA Binding and Cleavage by the Fowlpox Virus Resolvase. J. Biol. Chem.
284: 1190-1201
[Abstract]
[Full Text]
-
Lin, Y.-C. J., Li, J., Irwin, C. R., Jenkins, H., DeLange, L., Evans, D. H.
(2008). Vaccinia Virus DNA Ligase Recruits Cellular Topoisomerase II to Sites of Viral Replication and Assembly. J. Virol.
82: 5922-5932
[Abstract]
[Full Text]
-
Culyba, M. J., Minkah, N., Hwang, Y., Benhamou, O.-M. J., Bushman, F. D.
(2007). DNA Branch Nuclease Activity of Vaccinia A22 Resolvase. J. Biol. Chem.
282: 34644-34652
[Abstract]
[Full Text]
-
Meng, X., Embry, A., Sochia, D., Xiang, Y.
(2007). Vaccinia Virus A6L Encodes a Virion Core Protein Required for Formation of Mature Virion. J. Virol.
81: 1433-1443
[Abstract]
[Full Text]
-
Garcia, A. D., Otero, J., Lebowitz, J., Schuck, P., Moss, B.
(2006). Quaternary Structure and Cleavage Specificity of a Poxvirus Holliday Junction Resolvase. J. Biol. Chem.
281: 11618-11626
[Abstract]
[Full Text]
-
Chung, C.-S., Chen, C.-H., Ho, M.-Y., Huang, C.-Y., Liao, C.-L., Chang, W.
(2006). Vaccinia Virus Proteome: Identification of Proteins in Vaccinia Virus Intracellular Mature Virion Particles. J. Virol.
80: 2127-2140
[Abstract]
[Full Text]
-
Eckert, D., Williams, O., Meseda, C. A., Merchlinsky, M.
(2005). Vaccinia Virus Nicking-Joining Enzyme Is Encoded by K4L (VACWR035). J. Virol.
79: 15084-15090
[Abstract]
[Full Text]
-
da Fonseca, F. G., Weisberg, A. S., Caeiro, M. F., Moss, B.
(2004). Vaccinia Virus Mutants with Alanine Substitutions in the Conserved G5R Gene Fail To Initiate Morphogenesis at the Nonpermissive Temperature. J. Virol.
78: 10238-10248
[Abstract]
[Full Text]
-
Grubisha, O., Traktman, P.
(2003). Genetic Analysis of the Vaccinia Virus I6 Telomere-Binding Protein Uncovers a Key Role in Genome Encapsidation. J. Virol.
77: 10929-10942
[Abstract]
[Full Text]
-
Da Fonseca, F., Moss, B.
(2003). Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription. Proc. Natl. Acad. Sci. USA
100: 11291-11296
[Abstract]
[Full Text]
-
Chiu, W.-L., Chang, W.
(2002). Vaccinia Virus J1R Protein: a Viral Membrane Protein That Is Essential for Virion Morphogenesis. J. Virol.
76: 9575-9587
[Abstract]
[Full Text]
-
Punjabi, A., Boyle, K., DeMasi, J., Grubisha, O., Unger, B., Khanna, M., Traktman, P.
(2001). Clustered Charge-to-Alanine Mutagenesis of the Vaccinia Virus A20 Gene: Temperature-Sensitive Mutants Have a DNA-Minus Phenotype and Are Defective in the Production of Processive DNA Polymerase Activity. J. Virol.
75: 12308-12318
[Abstract]
[Full Text]